Valuation (84%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.98 | 16.25 |
| PEG Ratio (TTM) | 14.61 | 1.70 |
| P/S Ratio (TTM) | 0.61 | 2.61 |
| P/B Ratio (TTM) | 0.95 | 1.90 |
| P/FCF Ratio (TTM) | 0.73 | 11.14 |
| Price to 5YR AVG Earnings Ratio | 1.47 | 14.10 |
| Price to 5YR AVG FCF Ratio | 0.61 | 8.07 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.65% | 1,502.82% |
| ROE (TTM) | 7.89% | 8.88% |
| Net Profit Margin (TTM) | 5.34% | 15.60% |
| ROIC 5YR AVG | 11.35% | 20.57% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 31.21% | 12.23% | 1.01% |
| Revenue | 50.06% | 6.38% | 40.67% |
| Net Income | 28.47% | 16.14% | 1.43% |
| Cash Flow | 126.23% | 153.71% | 188.37% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.01 | 3.19 |
| Quick Ratio (TTM) | 55.97 | 4.91 |
| D/E Ratio (TTM) | 3.99 | 1.27 |
| Interest Coverage (TTM) | 0.05 | 0.64 |
| Piotroski F-Score | 9 | 6 |
| Altman Z-Score | 0.46 | 0.38 |
| LTL to 5YR AVG FCF | 7.16 | 6.26 |
| Shares Outstanding Growth 5YR AVG | 0.09% | 4.88% |